hDMT/RARE-NL Preclinical Network
Most innovations in therapy development for rare diseases start in academia. But how to translate your findings from the lab into a new therapy?

In this meeting, experts will showcase how they used human disease models to kickstart their therapy development pipeline, and what hurdles they had to overcome to get here. Learn how to start working on your own therapy development plan and anticipate the next steps in translating your findings to the clinic.

Preclinical Network for Rare diseases
By joining forces RARE-NL and hDMT (the Institute for Human organ and Disease Model Technologies) aim to set up a Preclinical Network for Rare diseases.

For whom
This meeting is specifically aimed at preclinical researchers who use in vitro and in vivo preclinical disease models to develop therapy strategies for rare diseases. Regulators and other stakeholders in this area are also welcome to join.

When and where
Wednesday 11 March 2026, LUMC

Program and Registration
The program is below, to secure your spot use this registration link.

A RARE-NL meeting on n-of-few AONs will take place in the afternoon of the same day. For more information see this page.